Metabolic Myopathies Management
Diagnostic Principles
- The European Heart Journal suggests that mitochondrial disorders can manifest during prolonged, low-intensity endurance activities or fasting states, and are characterized by progressive fixed weakness, multisystem features, and maternal inheritance pattern 2
- The European Respiratory Journal recommends cycle ergometry with lactate measurement to diagnose metabolic myopathies, as excessive lactate elevation suggests mitochondrial dysfunction 4
- The Mayo Clinic Proceedings states that muscle biopsy remains the gold standard for confirming metabolic myopathy diagnosis and differentiating between categories, with characteristic findings such as glycogen accumulation in GSDs, lipid accumulation in FAODs, and ragged red fibers in mitochondrial disorders 5
Management Principles
- The American College of Medical Genetics recommends enzyme replacement therapy (alglucosidase alfa) for Pompe disease, as well as avoiding fasting, maintaining euglycemia, and following a high-protein diet with frequent meals 1
- The European Heart Journal suggests that supportive care, including treating cardiac arrhythmias and diabetes, is essential for managing mitochondrial disorders 2
- The Genetics in Medicine journal recommends avoiding succinylcholine in all metabolic myopathies due to rhabdomyolysis risk, maintaining normoglycemia perioperatively, and monitoring for respiratory complications 1
Pregnancy and Surgical Considerations
- The American College of Medical Genetics recommends maintaining strict euglycemia throughout pregnancy in GSDs to prevent fetal demise, avoiding fasting and ketosis, and monitoring hepatic adenomas 1
- The Genetics in Medicine journal suggests planning delivery at a tertiary center with metabolic team coordination for patients with metabolic myopathies 1